Fusion Pharmaceuticals Inc.
NASDAQ: FUSN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- John F. Valliant
- Employees
- 101
- Headquarters
- Hamilton, Canada
- IPO year
- 2020
- Market cap
- $1.8B
- Website
- https://fusionpharma.com
Loading FUSN…
Loading profile data…Frequently asked questions about FUSN
What does Fusion Pharmaceuticals Inc. (FUSN) do?
Fusion Pharmaceuticals Inc. is a clinical-stage oncology enterprise focused on creating precise radiopharmaceutical therapies. The company utilizes its groundbreaking Targeted Alpha Therapies platform, which incorporates its exclusive Fast-Clear linker technology. This innovative system enables the attachment of alpha particle-emitting isotopes...
Where does FUSN trade?
Fusion Pharmaceuticals Inc. (FUSN) trades on the NASDAQ Global Select.
What sector is FUSN in?
Fusion Pharmaceuticals Inc. (FUSN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Fusion Pharmaceuticals Inc.?
John F. Valliant is the chief executive officer of Fusion Pharmaceuticals Inc. (FUSN).
Where is Fusion Pharmaceuticals Inc. headquartered?
Fusion Pharmaceuticals Inc. is headquartered in Canada.
Does FUSN pay a dividend?
Fusion Pharmaceuticals Inc. (FUSN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did FUSN go public?
Fusion Pharmaceuticals Inc. (FUSN) completed its initial public offering in 2020.